Page 1 of 1

Administration has only formally approved

Posted: Sat Jul 12, 2025 10:07 am
by shoponhossaiassn
As is the case with adults, medicines like the antiviral tecovirimat or TPOXX are available for treating monkeypox cases in children and have been safely given to children in the past. However, the CDC says no clinical studies have specifically investigated use of the antiviral in children.

The agency said that both children are being treated with tecovirimat.

For vaccination, Food and Drug the Jynneos monkeypox shots for use in adults. However, federal health officials have said the Biden administration has worked out arrangements to be able to offer doses for children in the current outbreak.

In June, CDC officials said that they had offered doses of the Jynneos vaccine to at least one pediatric patient. This week, a hospital in New Jersey announced they had facilitated vaccination of a 3-year-old who had been exposed to a positive case.

CDC scientists have estimated that monkeypox symptoms during buy phone number list the current outbreak take a little over a week on average to develop, following exposure to an infected person.

During that incubation period, the CDC says taking the two-dose monkeypox vaccine can still reduce the severity of the disease or even prevent it from developing.

"CDC recommends that the vaccine be given within 4 days from the date of exposure in order to prevent onset of the disease. If given between 4–14 days after the date of exposure, vaccination may reduce the symptoms of disease, but may not prevent the disease," the agency says in its guidance.

A spokesperson for the Food and Drug Administration declined to confirm how many requests the agency has granted for use of the vaccine in children.